Monte Rosa Therapeutics
IPODegrading proteins, making medicines
Public · Boston, United States · Founded 2018 · $127.5M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- monterosatx.com
- Total Funding
- $127.5M
- Last Round
- $95.0M Series CMar 2021
- Rounds
- 2
- Type
- Public
About
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing molecular glue degrader (MGD) medicines that reprogram ubiquitin ligases to eliminate disease-driving proteins previously considered undruggable. The company's proprietary platform integrates MGD chemistry, AI, structural biology, and proteomics to advance programs targeting cancer and other serious diseases.
Summary
Monte Rosa Therapeutics is a Biotech company based in Boston, United States, founded in 2018. It has raised $127.5M in total across 2 rounds, most recently a $95.0M Series C round in Mar 2021. Investors include Avoro Ventures, NEA and Jerel Davis.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2021
Sign up to see all 3 rounds
Series B through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/monte-rosa-therapeutics"><img src="https://indexed.vc/api/badge/company/monte-rosa-therapeutics" alt="Monte Rosa Therapeutics on Indexed.vc" width="260" height="76" /></a>